Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2026-01-02 @ 1:05 AM
Study NCT ID:
NCT01795859
Status:
COMPLETED
Last Update Posted:
2017-09-20
First Post:
2013-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
First Time Use of SD-809 in Huntington Disease
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08-05
Start Date Type:
ACTUAL
Primary Completion Date:
2014-12-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-12-05
Completion Date Type:
ACTUAL
First Submit Date:
2013-02-20
First Submit QC Date:
None
Study First Post Date:
2013-02-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-05-05
Results First Submit QC Date:
None
Results First Post Date:
2017-08-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-07-17
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-08-22
Last Update Post Date:
2017-09-20
Last Update Post Date Type:
ACTUAL